Epidemiology

Intracranial Atherosclerosis

Volumn , Issue , 2009, Pages 33-44

  Gorelick, Philip ^a   Han, Jinghao ^b   Huang, Yining ^c   Wong, K S Lawrence ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Conventional cerebral angiography based studies of racial differences in ICAS; Intracranial atherosclerosis (ICAS) important cause of stroke worldwide; MR angiography and TCD studies; Prevalence of ICAS in Chinese population; Sex differences in ICAS autopsy study; Symptomatic ICAS in Europe; Symptomatic ICAS in stroke patients

Indexed keywords

EID: 67650068048     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300673.ch3     Document Type: Chapter

References (82)

1. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17: 648-655.
2. Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993; 24: 116-19; discussion 120-121.
3. Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 1984; 34: 54-59.
4. Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of posterior circulation occlusive disease. Stroke 1985; 16: 785-790.
5. Gorelick PB, Caplan LR, Langenberg P, et al. Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease. Neurology. 1988; 38: 852-858.
6. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316.
7. Wong LKS. Global burden of intracranial atherosclerosis. International Journal of Stroke. 2006; 1: 158-159.
8. Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 65: 296-298.
9. Nam HS, Han SW, Lee JY, et al. Association of aortic plaque with intracranial atherosclerosis in patients with stroke. Neurology 2006; 67: 1184-1188.
10. Suh DC, Lee SH, Kim KR, et al. Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol 2003; 24: 239-244.
11. Bae HJ, Yoon BW, Kang DW, et al. Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis 2006; 21: 112-119.
12. Thomas GN, Lin JW, Lam WW, et al. Middle cerebral artery stenosis in type II diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes. Cerebrovasc Dis 2003; 16: 217-223.
13. Thomas GN, Lin JW, Lam WW, et al. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients. Diabetologia 2004; 47: 1528-1534.
14. Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 2007; 6: 407-413.
15. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36: 782-786.
16. McGarry P, Solberg LA, Guzman MA, Strong JP. Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest 1985; 52: 533-539.
17. Nakamura M, Yamamoto H, Kikuchi Y, et al. Cerebral atherosclerosis in Japanese. I. Age related to atherosclerosis. Stroke 1971; 2: 400-408.
18. Resch JA, Okabe N, Loewenson RB, et al. Pattern of vessel involvement in cerebral atherosclerosis. A comparative study between a Japanese and Minnesota population. J Atheroscler Res 1969; 9: 239-250.
19. Masuda J, Tanaka K, Omae T, et al. Cerebrovascular diseases and their underlying vascular lesions in Hisayama, Japan-a pathological study of autopsy cases. Stroke 1983; 14: 934-940.
20. Koyama S, Saito Y, Yamanouchi H, et al. [Marked decrease of intracranial atherosclerosis in contrast with unchanged coronary artery stenosis in Japan]. Nippon Ronen Igakkai Zasshi 2003; 40: 267-273.
21. Leung SY, Ng TH, Yuen ST, et al. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 1993; 24: 779-786.
22. Liu F, Zhang B, Tian Y. [Morphological changes in intracranial and extracranial arteries of autopsy cases of cerebrovascular diseases]. Zhonghua Yi Xue Za Zhi 1996; 76: 832-835.
23. Chen XY, Wong KS, Lam WW, et al. Middle Cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2007; 25: 74-80.
24. Wong KS, Huang YN, Yang HB, et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology 2007; 68: 2031-2034.
25. Huang HW, Guo MH, Lin RJ, et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis 2007; 24: 111-115.
26. Huang HW, Guo MH, Lin RJ, et al. Hyperhomocysteinemia is a risk factor of middle cerebral artery stenosis. J Neurol 2007; 254: 364-367.
27. Hill AB. Should patients be screened for asymptomatic carotid artery stenosis? Can J Surg 1998; 41: 208-213.
28. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003; 34: 2361-2366.
29. Wong KS, Ng PW, Tang A, et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007; 68: 2035-2038.
30. Park KY, Chung CS, Lee KH, et al. Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic Korean population. J Clin Neurol 2006; 2: 29-33.
31. Uehara T, Tabuchi M, Mori E. Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Evaluation by MR angiography. Cerebrovasc Dis 1998; 8: 267-272.
32. Uehara T, Tabuchi M, Kozawa S, Mori E. MR angiographic evaluation of carotid and intracranial arteries in Japanese patients scheduled for coronary artery bypass grafting. Cerebrovasc Dis 2001; 11: 341-345.
33. Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006; 66: 1344-1349.
34. Nishimaru K, McHenry LC, Jr, Toole JF. Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke 1984; 15: 56-59.
35. Brust RW, Jr. Patterns of cerebrovascular disease in Japanese and other population groups in Hawaii: an angiographical study. Stroke 1975; 6: 539-542.
36. Ryu SJ. Angiographic features in Chinese patients with occlusive cerebrovascular disease. Stroke 1987; 18: 686.
37. Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541-1545.
38. Thajeb P. Large vessel disease in Chinese patients with capsular infarcts and prior ipsilateral transient ischaemia. Neuroradiology 1993; 35: 190-195.
39. Kim JT, Yoo SH, Kwon J-H, Kwon SU, Kim JS. Subtyping of ischemic stroke based on vascular imaging: analysis of 1,167 acute, consecutive patients. J Clin Neurol 2006; 2: 225-230.
40. Takahashi K, Kitani M, Fukuda H, Kobayashi S. Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA). Acta Neurol Scand 1999; 100: 395-399.
41. Padma MV, Gaikwad S, Jain S, et al. Distribution of vascular lesions in ischaemic stroke: a magnetic resonance angiographic study. Natl Med J India 1997; 10: 217-220.
42. Kaul S, Sunitha P, Suvarna A, et al. Subtypes of Ischemic Stroke in a Metropolitan City of South India (One year data from a hospital based stroke registry). Neurol India 2002; 50 (Suppl): S8-S14s.
43. De Silva DA, Woon FP, Pin LM, et al. Intracranial large artery disease among OCSP subtypes in ethnic South Asian ischemic stroke patients. J Neurol Sci 2007; 260: 147-149.
44. Li H, Wong KS. Racial distribution of intracranial and extracranial atherosclerosis. J Clin Neurosci 2003; 10: 30-34.
45. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003; 22: 37-40.
46. Zhou H, Wang YJ, Wang SX, Zhao XQ. [TOAST subtyping of acute ischemic stroke]. Zhonghua Nei Ke Za Zhi 2004; 43: 495-498.
47. Liu HM, Tu YK, Yip PK, Su CT. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke 1996; 27: 650-653.
48. Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997; 48: 524-525.
49. Wong KS, Huang YN, Gao S, et al. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812-813.
50. Wong KS, Li H, Chan YL, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000; 31: 2641-2647.
51. Li H, Wong KS, Kay R. Relationship between the Oxfordshire Community Stroke Project classification and vascular abnormalities in patients with predominantly intracranial atherosclerosis. J Neurol Sci 2003; 207: 65-69.
52. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006; 66: 1187-1191.
53. Olsen TS, Skriver EB, Herning M. Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion. Stroke 1985; 16: 459-466.
54. Sanchez-Sanchez C, Egido JA, Gonzalez-Gutierrez JL, et al. [Stroke and intracranial stenosis: clinical profile in a series of 134 patients in Spain]. Rev Neurol 2004; 39: 305-311.
55. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475-1482.
56. Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 1951; 65: 346-377.
57. Hutchinson EC, Yates PO. Carotico-vertebral stenosis. Lancet 1957; 272: 2-8.
58. Baker AB, Iannone A. Cerebrovascular disease. I. The large arteries of the circle of Willis. Neurology 1959; 9: 321-332.
59. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982; 32: 871-876.
60. Moossy J. Development of cerebral atherosclerosis in various age groups. Neurology 1959; 9: 569-574.
61. Moossy J. Cerebral infarction and intracranial arterial thrombosis. Necropsy studies and clinical implications. Arch Neurol 1966; 14: 119-123.
62. Flora GC, Baker AB, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968; 38: 859-869.
63. Fields WS, North RR, Hass WK, et al. Joint study of extracranial arterial occlusion as a cause of stroke. I. Organization of study and survey of patient population. JAMA 1968; 203: 955-960.
64. Heyden S, Heyman A, Goree JA. Nonembolic occlusion of the middle cerebral and carotid arteries-a comparison of predisposing factors. Stroke 1970; 1: 363-369.
65. Heyman A, Karp HR, Heyden S, et al. Cerebrovascular disease in the biracial population of Evans County, Georgia. Arch Intern Med 1971; 128: 949-955.
66. Russo LS, Jr. Carotid system transient ischemic attacks: clinical, racial, and angiographic correlations. Stroke 1981; 12: 470-473.
67. Bauer RB, Sheehan S, Wechsler N, Meyer JS. Arteriographic study of sites, incidence, and treatment of arteriosclerotic cerebrovascular lesions. Neurology 1962; 12: 698-711.
68. Kuller LH. Introduction and overview commentary. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke in blacks. A guide to management and prevention. Basel: S. Karger AG, 1999, pp. 1-6.
69. Caplan LR. Cerebral ischemia and infarction in blacks. Clinical, autopsy and angiographic studies. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke in blacks. A guide to management and prevention. Basel: S. Karger AG, 1999, pp. 7-18.
70. Inzitari D, Hachinski VC, Taylor DW, Barnett HJ. Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol 1990; 47: 1080-1084.
71. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Raceethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14-20.
72. Sacco RL, Roberts JK, Boden-Albala B, et al. Raceethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke 1997; 28: 929-935.
73. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555-563.
74. Burke GL, Howard G. Ethnic differences in cerebral atherosclerosis. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke in blacks. A guide to management and prevention. Basel: S. Karger AG 1999, pp. 94-105.
75. Oda K, Tanaka N, Arai T, et al. Polymorphisms in proand anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 2007; 16: 592-599.
76. Robinet P, Vedie B, Chironi G, et al. Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis 2003; 168: 381-387.
77. Markus HS, Labrum R, Bevan S, et al. Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 2006; 37: 2253-2259.
78. Fiotti N, Altamura N, Fisicaro M, et al. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26: 1330-1336.
79. Wang L, Gu Y, Wu G, et al. [A case control study on the distribution of apolipoprotein AI gene polymorphisms in the survivors of atherosclerosis cerebral infarction]. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 22-25.
80. Sertic J, Hebrang D, Janus D, et al. Association between deletion polymorphism of the angiotensin-converting enzyme gene and cerebral atherosclerosis. Eur J Clin Chem Clin Biochem 1996; 34: 301-304.
81. Liu ZZ, Lv H, Gao F, et al. Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis. Clin Chim Acta 2008; 389: 40-44.
82. Abboud S, Karhunen PJ, Lutjohann D, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS ONE 2007; 2: e1043.